Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,956.00
Bid: 1,964.00
Ask: 1,966.00
Change: -4.00 (-0.20%)
Spread: 2.00 (0.102%)
Open: 1,994.00
High: 2,000.00
Low: 1,956.00
Prev. Close: 1,960.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Soft Pound Supports FTSE 100 But Pearson Falls

Wed, 18th Jan 2017 12:15

LONDON (Alliance News) - Stock prices in London were mixed Wednesday at midday with the FTSE 100 index benefiting as the pound gave back some of the strong gains seen on Tuesday after UK Prime Minister Theresa May's speech on her Brexit plans.

But company news also came back to the fore. Shares in education publisher Pearson, facilities management firm Mitie Group, and Mr Kipling cake baker Premier Foods were down, after all issued profit warnings.

On the upside, Hikma Pharmaceuticals was rising after getting US approval for one its generic drugs, while luxury fashion retailer Burberry Group was benefiting from a good trading update.

The FTSE 100 index was up 0.1%, or 6.89 points, at 7,227.27. The FTSE 250 was 0.1% lower at 18,223.11, while the AIM All-Share was flat at 872.23.

Blue-chip Burberry was up 2.2%, the biggest FTSE 100 gainer. It reported growth in revenue in the third quarter of its financial year thanks to a big boost from the weak pound, as it said full-year profit will be in line with market expectations.

Burberry said retail revenue in the three months to December 31 grew by 22% year-on-year to GBP735.0 million. On an underlying basis at constant currencies, retail revenue rose by 4%.

Hikma was up 1.8% after the Jordanian drugmaker said its Roxane Laboratories subsidiary in the US has received approval for its sodium oxybate oral product.

Meanwhile, Pearson was down 28% after it withdrew its ambitious operating profit target for 2018 and warned on its outlook for 2017, following a slump in its North American higher-education courseware business in the final months of 2016.

The publisher group said the fourth quarter of 2016 had seen an "unprecedented decline" in its North American higher education courseware business, which includes printed text books and that Pearson said was "much weaker than expected".

In the FTSE 250, Mitie was down 6.9% after it reported further contract woes and said its underlying annual profit is set to about halve. Mitie said underlying operating profit for the year to March 31 will be between GBP60.0 million and GBP70.0 million, down from GBP128.9 million a year before.

Mitie said strains on the company's businesses have yet to abate. Since reporting a swing to loss in November, the group said its board has met to consider the trading outlook for the remainder of the year to the end of March. Its Property Management and Technical Facilities Management divisions have been hit by client deferrals and investment plan delays, meaning some work for these units will be pushed into the 2018 financial year.

Inmarsat was down 5.1% after JPMorgan downgraded the satellite communications provider to Neutral from Overweight.

Among mid-cap gainers was Ladbrokes Coral Group, up 3.7%. The newly merged bookmaker said it expects profit in 2016 to increase in line with market consensus and management expectations, despite seeing poor sporting results in the second half of December.

In the London Main Market, Premier Foods was down 15%. The firm, which also makes brands including Bisto gravy and Homepride cooking sauces, said it suffered weak sales in the third quarter of its financial year. It warned on increased input costs as a result of the weak pound, leading it to trim its trading profit expectations for the full year.

The pound was quoted at USD1.2291 compared to USD1.2416 at the London equities close on Tuesday. Sterling had sharply appreciated during UK Prime Minister May's speech on Tuesday as it offered more clarity on the UK's position and as the PM confirmed that both Houses of Parliament will vote on the final Brexit deal.

The currency barely reacted to a UK jobs report from the Office for National Statistics released Wednesday morning. The unemployment rate remained stable in three months to November and people claiming unemployment benefits declined unexpectedly.

The jobless rate came in at 4.8%, the lowest since September 2005 and matched economists' expectations. In three months to November, unemployment decreased by 52,000 from August to 1.6 million.

Average earnings including bonus increased 2.8% from previous year and earnings excluding bonus advanced 2.7%. The claimant count held steady at 2.3% in December as economists had expected. The number of people claiming unemployment related benefits decreased by 10,100 from November.

There also were consumer inflation reports from Germany and the eurozone. Inflation in Germany was 1.7% year-on-year in December, confirming the preliminary data. In November, prices had risen at a stable pace of 0.8%. On a monthly basis, consumer prices climbed 0.7% from November, when it increased by 0.1%. The figure also matched preliminary report.

Eurostat data showed eurozone inflation accelerated to 1.1% in December from 0.6% in November, still below the European Central Bank's target of 'below, but close to 2%'. Month-on-month, consumer prices gained 0.5% in December.

Core inflation that excludes energy, food, alcohol and tobacco, rose only slightly to 0.9% from 0.8% year-on-year. On a monthly basis, core inflation rose to 0.4%, reversing a decline of 0.2% in November.

The ECB publishes its monetary policy decision on Thursday at 1245 GMT.

The CAC 40 index in Paris was down 0.4%, while the DAX 30 in Frankfurt was up 0.1%.

In New York, stocks were called for a higher open, with the Dow 30 and S&P 500 indices both seen up 0.1%, while the Nasdaq Composite was pointed up 0.2%.

In the US economic calendar, MBA mortgage applications are at 1200 GMT, consumer inflation is at 1330 GMT and industrial production is at 1415 GMT. US Federal Reserve Chair Janet Yellen will speak in San Francisco at 2000 GMT, and the API weekly crude oil stocks are at 2130 GMT.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2017 Alliance News Limited. All Rights Reserved.

More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.